| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
728 |
| issn |
1368-5031
1742-1241 |
| issueIdentifier |
8 |
| pageRange |
726-728 |
| publicationName |
International Journal of Clinical Practice |
| startingPage |
726 |
| bibliographicCitation |
Glynn O. EUROPA shows role for ACE inhibition in low‐risk CHD. Int J Clinical Practice. 2003 Oct;57(8):726–8. doi: 10.1111/j.1742-1241.2003.tb10596.x. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44f3970a12a2b499a17e9f46db86ce95 |
| date |
200310 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/14627186
https://doi.org/10.1111/j.1742-1241.2003.tb10596.x |
| isPartOf |
https://portal.issn.org/resource/ISSN/1368-5031
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20688
https://portal.issn.org/resource/ISSN/1742-1241 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
EUROPA shows role for ACE inhibition in low‐risk CHD |
| discusses |
http://id.nlm.nih.gov/mesh/M0217705
http://id.nlm.nih.gov/mesh/M0021253
http://id.nlm.nih.gov/mesh/M0002348
http://id.nlm.nih.gov/mesh/M0001207
http://id.nlm.nih.gov/mesh/M0129811
http://id.nlm.nih.gov/mesh/M0001456
http://id.nlm.nih.gov/mesh/M0002570 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D006333Q000188
http://id.nlm.nih.gov/mesh/D000806Q000627
http://id.nlm.nih.gov/mesh/D020913Q000627
http://id.nlm.nih.gov/mesh/D000959Q000627
http://id.nlm.nih.gov/mesh/D001562Q000627
http://id.nlm.nih.gov/mesh/D013777Q000627
http://id.nlm.nih.gov/mesh/D003327Q000188 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006333Q000401
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D001713
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D006801 |